Jarkko Ahvonen
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.
Journal: Molecular oncology
Published: March 23, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 12, 2025
Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study.
Journal: Cancer treatment and research communications
Published: October 02, 2025
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.
Journal: Frontiers in oncology
Published: August 07, 2025
Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Real-World Study.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 26, 2025
Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 17, 2023
Survival with lung cancer in Finland has not improved during 2007-2019-a single center retrospective population-based real-world study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 31, 2023
Trends in treatment of non-small cell lung cancer in Finland 2014-2019.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 12, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026